MBZUAI's Professor Le Song is developing an AI-driven simulation to model the human body at societal, organ, tissue, cellular, and molecular levels. The goal is to reduce the time and cost associated with bringing new medicines to market by removing the need for wet lab biological research. Song aims to create a comprehensive model using machine learning. Why it matters: This research could revolutionize drug discovery in the region by accelerating the development process and reducing reliance on traditional research methods.
Fudan University's Zhongyu Wei presented research on social simulation driven by LLMs, covering individual and large-scale social movement simulation. Wei directs the Data Intelligence and Social Computing Lab (Fudan DISC) and has published extensively on multimodal large models and social computing. His work includes the Volcano multimodal model, DISC-MedLLM, and ElectionSim. Why it matters: Using LLMs for social simulation could provide new tools for understanding and potentially predicting social dynamics in the Arab world.
KAUST and EPFL Blue Brain Project researchers propose a new theory about a 'secret language' used by cells for internal communication regarding the external world. Using a computational model, they suggest that metabolic pathways can code details about neuromodulators that stimulate energy consumption. The model focuses on astrocytes and their cooperation with neurons in fueling the brain. Why it matters: This suggests a new avenue for understanding information processing in the brain and how cells contribute to the energy efficiency of brains compared to computers.
A KAUST alumnus presented research on using large language models for complex disease modeling and drug discovery. LLMs were trained on insurance claims of 123 million US people to model diseases and predict genetic parameters. Protein language models were developed to discover remote homologs and functional biomolecules, while RNA language models were used for RNA structure prediction and reverse design. Why it matters: This work highlights the potential of LLMs to accelerate computational biology research and drug development, with a KAUST connection.
A KAUST research team is using cellphone mobility data, Google searches, and social media to model and predict COVID-19 spread. The models aim to forecast cases in the coming weeks and inform resource allocation, including hospital beds and medical staff. The team is using aggregated and anonymized data from cellphone companies to respect people's privacy. Why it matters: Integrating real-time digital data with epidemiological modeling can improve the speed and effectiveness of public health responses in the region and globally.
Krishna Murthy, a postdoc at MIT, researches computational world models to enable robots to understand and operate effectively in the physical world. His work focuses on differentiable computing approaches for spatial perception and interfaces large image, language, and audio models with 3D scenes. Murthy envisions structured world models working with scaling-based approaches to create versatile robot perception and planning algorithms. Why it matters: This research could significantly advance robotics by enabling more sophisticated perception, reasoning, and action capabilities in embodied agents.
KAUST researchers developed a new model integrating SIR compartment modeling in time and a point process modeling approach in space-time, also considering age-specific contact patterns. They used a two-step framework to model infectious locations over time for different age groups. The model demonstrated improved predictive accuracy in simulations and a COVID-19 case study in Cali, Colombia, compared to existing models. Why it matters: This model can assist decision-makers in identifying high-risk locations and vulnerable populations for better disease control strategies in the region and globally.
Carlo Maj from the University of Marburg will discuss using polygenic modeling to analyze the genetic architecture of multifactorial traits. He will present how these approaches can be used to predict the genetically driven components of complex phenotypes. The talk highlights the potential of these methods to bridge genomic research and genetic epidemiology using biobank data. Why it matters: Such methods could improve disease risk assessment and advance personalized risk management in the region if applied to local biobanks or datasets.